1 | changes | 55,873 |
2 | alterations | 4,663 |
3 | alternations | 44 |
4 | divergences | 30 |
5 | neuroadaptations | 16 |
6 | pseudohyperkalaemia | 8 |
7 | convolutions | 6 |
8 | v-waves | 6 |
9 | cobenefits | 4 |
10 | victories | 4 |
11 | esthélis | 3 |
12 | hypercalcitoninemia | 3 |
13 | myoliquefaction | 3 |
14 | remaksol | 3 |
15 | 1,3-diamines | 2 |
16 | coarse-graining | 2 |
17 | maturogenesis | 2 |
18 | non-cooperation | 2 |
19 | over-activations | 2 |
20 | pak1/2 | 2 |
21 | surveillances | 2 |
22 | δci | 2 |
23 | -variations | 1 |
24 | 1/1/2001-31/12/2010 | 1 |
25 | 1945-1995 | 1 |
26 | 1982-1993 | 1 |
27 | 1987-2014 | 1 |
28 | 21-27d | 1 |
29 | bronchohyperresponsiveness | 1 |
30 | carbomonoxide | 1 |
31 | chorionamniositis | 1 |
32 | chromogens | 1 |
33 | coq10/cholesterol | 1 |
34 | cytostasis | 1 |
35 | dnaj/hsp40 | 1 |
36 | fish-oil-supplementation | 1 |
37 | folfox/bevacizumab/cetuximab | 1 |
38 | hebephilia-as-disorder | 1 |
39 | hsp27-regulation | 1 |
40 | imiquimod/ta-cin | 1 |
41 | k47 | 1 |
42 | mins/cr | 1 |
43 | monitor-cardioverter-defibrillator | 1 |
44 | nitrosurea | 1 |
45 | pardee-q-wave | 1 |
46 | pronociception | 1 |
47 | rs2243115 | 1 |
48 | rvfunction | 1 |
49 | screenshots | 1 |
50 | semiography | 1 |
51 | somsto-types | 1 |
52 | source-imaging | 1 |
53 | tissue-damage | 1 |
1 | -variations | 1 |
2 | 1,3-diamines | 2 |
3 | 1/1/2001-31/12/2010 | 1 |
4 | 1945-1995 | 1 |
5 | 1982-1993 | 1 |
6 | 1987-2014 | 1 |
7 | 21-27d | 1 |
8 | alterations | 4,663 |
9 | alternations | 44 |
10 | bronchohyperresponsiveness | 1 |
11 | carbomonoxide | 1 |
12 | changes | 55,873 |
13 | chorionamniositis | 1 |
14 | chromogens | 1 |
15 | coarse-graining | 2 |
16 | cobenefits | 4 |
17 | convolutions | 6 |
18 | coq10/cholesterol | 1 |
19 | cytostasis | 1 |
20 | divergences | 30 |
21 | dnaj/hsp40 | 1 |
22 | esthélis | 3 |
23 | fish-oil-supplementation | 1 |
24 | folfox/bevacizumab/cetuximab | 1 |
25 | hebephilia-as-disorder | 1 |
26 | hsp27-regulation | 1 |
27 | hypercalcitoninemia | 3 |
28 | imiquimod/ta-cin | 1 |
29 | k47 | 1 |
30 | maturogenesis | 2 |
31 | mins/cr | 1 |
32 | monitor-cardioverter-defibrillator | 1 |
33 | myoliquefaction | 3 |
34 | neuroadaptations | 16 |
35 | nitrosurea | 1 |
36 | non-cooperation | 2 |
37 | over-activations | 2 |
38 | pak1/2 | 2 |
39 | pardee-q-wave | 1 |
40 | pronociception | 1 |
41 | pseudohyperkalaemia | 8 |
42 | remaksol | 3 |
43 | rs2243115 | 1 |
44 | rvfunction | 1 |
45 | screenshots | 1 |
46 | semiography | 1 |
47 | somsto-types | 1 |
48 | source-imaging | 1 |
49 | surveillances | 2 |
50 | tissue-damage | 1 |
51 | v-waves | 6 |
52 | victories | 4 |
53 | δci | 2 |
1 | 1/1/2001-31/12/2010 | 1 |
2 | dnaj/hsp40 | 1 |
3 | pak1/2 | 2 |
4 | 1982-1993 | 1 |
5 | 1987-2014 | 1 |
6 | rs2243115 | 1 |
7 | 1945-1995 | 1 |
8 | k47 | 1 |
9 | nitrosurea | 1 |
10 | pseudohyperkalaemia | 8 |
11 | hypercalcitoninemia | 3 |
12 | folfox/bevacizumab/cetuximab | 1 |
13 | 21-27d | 1 |
14 | carbomonoxide | 1 |
15 | tissue-damage | 1 |
16 | pardee-q-wave | 1 |
17 | source-imaging | 1 |
18 | coarse-graining | 2 |
19 | δci | 2 |
20 | coq10/cholesterol | 1 |
21 | remaksol | 3 |
22 | imiquimod/ta-cin | 1 |
23 | hsp27-regulation | 1 |
24 | non-cooperation | 2 |
25 | fish-oil-supplementation | 1 |
26 | myoliquefaction | 3 |
27 | rvfunction | 1 |
28 | pronociception | 1 |
29 | mins/cr | 1 |
30 | hebephilia-as-disorder | 1 |
31 | monitor-cardioverter-defibrillator | 1 |
32 | surveillances | 2 |
33 | divergences | 30 |
34 | changes | 55,873 |
35 | victories | 4 |
36 | 1,3-diamines | 2 |
37 | somsto-types | 1 |
38 | v-waves | 6 |
39 | esthélis | 3 |
40 | cytostasis | 1 |
41 | maturogenesis | 2 |
42 | chorionamniositis | 1 |
43 | chromogens | 1 |
44 | -variations | 1 |
45 | alternations | 44 |
46 | alterations | 4,663 |
47 | neuroadaptations | 16 |
48 | over-activations | 2 |
49 | convolutions | 6 |
50 | bronchohyperresponsiveness | 1 |
51 | cobenefits | 4 |
52 | screenshots | 1 |
53 | semiography | 1 |